Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.03 – $1.23
3% from low
No one on the platform currently holds LSBCF.
No tracked institution reports a position in LSBCF as of their last filing.
No one on the platform has traded LSBCF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $1.8B | +24.3% | $36.57 | $36.57–$36.57 | 0.0× | 1 |
| 2028 | $2.0B | +9.9% | $45.04 | $45.04–$45.04 | 0.0× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 4 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-04-18 | $-0.60 | $-1.20 | -100.0% |
| 2025-01-27 | $-0.80 | $-1.60 | -100.0% |
| 2024-09-24 | $-0.58 | $-1.34 | -131.0% |
| 2024-04-19 | $-0.09 | $-0.08 | +10.8% |
| $25M |
| — |
| IGXTIntelGenx Technologies Corp. | $0.17 | +0.00% | $30M | — |
| IMMPFImmuPharma plc | $0.09 | +0.00% | $28M | — |
Source: Financial Modeling Prep · peers by sector/industry